Stockscreener 앱 받기
0.9502
2.61%
0.016
Vor Biopharma Inc 주식(VOR)의 최신 뉴스
Market Resilience: Vor Biopharma Inc (VOR) Finishes Weak at 0.93, Down -2.48 - The Dwinnex
Vor Biopharma Inc (VOR) requires closer examination - US Post News
Vornado Realty Trust (VNO) may enjoy gains as insiders got busy in the recent days - Knox Daily
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Aviat Networks, Inc. for potential violations of federal securities laws - AccessWire
What to expect from VNO’s earnings report this quarter? - US Post News
President Of Verona Pharma Sold 28% Of Their Shares - Simply Wall St
Daiwa Securities Group Inc. Sells 3,155 Shares of Varonis Systems, Inc. (NASDAQ:VRNS) - Defense World
Volatus Aerospace (CVE:VOL) Stock Price Down 1.9% - Defense World
ValiRx’s Inaphaea Inks Deal with Xenopat for Cancer Research - TipRanks
Varonis Systems Inc [VRNS] Stock sold by Insider O’Boyle James for $3.83 million - Knox Daily
'V/H/S/Beyond' Is About to Put a New Director on the Map in a Very Big & Wild Way [Exclusive] - Collider
Viromed Medical AG Plans to Acquire All Shares of ActivCell Group AG by Way of a Capital Increase Against Contribution in Kind with Exclusion of Subscription Rights - Financial Post
Recent Insider Activity Suggests Potential Gains for VOXX International Corp (VOXX) - Knox Daily
Vornado Realty Trust stock outperforms competitors on strong trading day - MarketWatch
Vornado Realty Trust (NYSE:VNO) Shares Sold by Daiwa Securities Group Inc. - Defense World
Victory Capital Management Inc. Purchases 7,762 Shares of Veralto Co. (NYSE:VLTO) - Defense World
Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares By GuruFocus - Investing.com Canada
California Biotech Reports Positive QOL Improvements in Program - Streetwise Reports
Wolf Popper LLP Announces Investigation on Behalf of Aviat Networks, Inc. Investors - GlobeNewswire
Biotech Co. Says New Data Show Success of Type 1 Diabetes Treatment - Streetwise Reports
Velo3D Leaves NYSE for Over-the-Counter Market—Here’s Why - 3DPrint.com
Insider Selling: Attar Eyal C., Vor Biopharma Inc [VOR] CHIEF MEDICAL OFFICER divested 14,645 shares - Knox Daily
Velo3D stock to be delisted from New York Stock Exchange; Company to begin trading on OTCQX Best Market - TCT Magazine
A better buy-in window may exist right now for Vor Biopharma Inc (VOR) - SETE News
Analytical Lens: Exploring Vor Biopharma Inc (VOR)’s Financial Story Through Ratios - The Dwinnex
VOR’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Vor Biopharma (NASDAQ:VOR) Will Have To Spend Its Cash Wisely - Simply Wall St
Biotech Working on 'Functional Cure' for Type 1 Diabetes - Streetwise Reports
MA Biotech Reports Positive Meeting with FDA - Streetwise Reports
Gene Editing Therapeutics Market Forecast 2024-2029: A $1 Billion Market by 2029, with a Forecasted CAGR of 147% - GlobeNewswire Inc.
How did Vor Biopharma Inc (VOR) fare last session? - US Post News
Medical Properties Trust, Inc. (NYSE:MPW) Position Trimmed by Van ECK Associates Corp - Defense World
Brokerages Set Vor Biopharma Inc. (NYSE:VOR) PT at $10.92 - MarketBeat
JMP Securities Reiterates Market Outperform Rating for Vor Biopharma (NYSE:VOR) - Defense World
HC Wainwright Reiterates “Buy” Rating for Vor Biopharma (NYSE:VOR) - Defense World
Principal Financial Group Inc. Has $10.28 Million Position in Molson Coors Beverage (NYSE:TAP) - Defense World
Thesis Gold (CVE:TAU) PT Raised to C$3.00 - Defense World
What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday? - MSN
Vor Biopharma (NYSE:VOR) Earns Market Outperform Rating from JMP Securities - MarketBeat
Vor’s stem cell transplant delays cancer relapse - BioWorld Online
Vor Biopharma Inc (VOR) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Mass. Biopharma Reports Positive Data & Announces New Program - Streetwise Reports
What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday? - Benzinga
Vor Biopharma stock holds price target, buy rating on positive study data - Investing.com
Ncino Inc. [NCNO] stock for 19,355 USD was sold by Orenstein Gregory - Knox Daily
A company insider recently sold 7,500 shares of Ardelyx Inc [ARDX]. Should You Sale? - Knox Daily
CHIEF MEDICAL OFFICER Attar Eyal C. sold 14,645 shares of Vor Biopharma Inc [VOR] - Knox Daily
Gaining Ground: Vor Biopharma Inc (VOR) Closes Lower at 0.82, Down -2.37 - The Dwinnex
Baird reiterates Outperform on Vor Biopharma as trem-cel data derisks safety profile - Investing.com
Vor Bio Announces New Clinical Data from Its Ongoing Phase 1/2 VBP101 Study of Patients with Relapsed/Refractory AML Receiving trem-cel Followed by Mylotarg? - Marketscreener.com
Vor Bio reports promising AML treatment data - Investing.com India
Aqua Metals Inc [AQMS] Shares Fall Approximately -81.89% Over the Year - Knox Daily
Vor Bio reports promising AML treatment data - Investing.com
Vor Bio stock rallies post-market on trem-cel study data - MSN
Vor Bio stock rallies post-market on trem-cel study data (NASDAQ:VOR) - Seeking Alpha
Vor Biopharma Advances Innovative Blood Cancer Therapies - TipRanks
Vor Bio reports promising AML treatment data By Investing.com - Investing.com UK
New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies - GlobeNewswire
New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies - Yahoo Finance
Here's Why Vor Biopharma (NASDAQ:VOR) Must Use Its Cash Wisely - Yahoo Finance
Dundee (TSE:DC.A) Shares Cross Above 50 Day Moving Average of $1.34 - Defense World
Examining Vor Biopharma Inc (VOR) stock is warranted - US Post News
Vor Biopharma Inc (VOR) expanding its growth trajectory ahead - SETE News
Vor Biopharma faces Nasdaq delisting over share price By Investing.com - Investing.com Canada
Vor Bio to Participate in Upcoming Investor Conferences - GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences - Marketscreener.com
Vor Bio to Participate in Upcoming Investor Conferences - Yahoo Finance
PureTech Health plc – Half-Year Report - Business Wire
Investing in Vor Biopharma Inc (VOR) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
0.98%
2.02%
자본화:
|
볼륨(24시간):